Skip to main content
OpenTrials
Completed

NCT Number: NCT07073651

Response of Lipid Profile to Virtual Reality Games Versus Moderate Aerobic Exercise Training in Children With Obesity

This trial is aiming to study the effect of virtual reality video gaming in comparison with moderate intensity aerobic exercises on lipid profile in children with Obesity

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obese Children and Adolescents Adolescent Obesity Body Mass Index Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pediatric Obesity Signs and Symptoms

Age range

11 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Badr University in Cairo faculty of physical therapy, Cairo, Egypt

Loading trial locations.

About this study

The study will assess whether virtual reality games, dietary advices and moderate intensity aerobic exercise lead to significant differences in lipid profile in class I obese adolescent children. Additionally, the study will examine whether these interventions has impacts on the children body mass index.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Obese adolescent children
  • age from 11 to 18 years old only.
  • Class I Obesity (Body Mass Index from 30 to 34.99 kg/m2)
  • Clinically and medically stable
  • Without any impairment of sensation or other neurological or psychological problems.

Exclusion criteria

  • Adolescents with visual and/or auditory defects
  • Normal weight adolescent children (Body Mass Index from 18 to 24.99 kg/m2) or below average weight (BMI less than 18 kg/m2) or Class II and III Obesity (BMI above 35 kg/m2)
  • Children with significant tightness and/or deformity of upper or lower limbs
  • Participants with neurological disorders that affect balance or mentality (e.g. epilepsy).
  • Adolescents with advanced radiographic changes include: Bone destruction, Bony ankylosis, Knee joint subluxation, and Epiphysial fracture)
  • Any lower limb deformities in the lower limbs.
  • Participants with cardiopulmonary diseases.
  • Diabetic children or those under insulin therapy, uncontrolled bronchial asthma, anemia, and Pathological causes of obesity (endocrinal, genetic syndromes...etc.).

Treatment and study plan

moderate intensity aerobic exercise

Other

moderate intensity aerobic exercises (using treadmill training) 5 times per week for 12 weeks. Each participating child started the session with 5 minutes of warming-up exercises. Then the main exercise phase is performed at 50-60% of age-predicted peak heart rate using a treadmill for 30 minutes. Finally, a 5 min cool-down period is allowed, the total session took 40 minutes.

Dietary Advices

Other

The Obese adolescent children participated in the study received diet advices based on a balanced low calorie diet (1500 Kcal)

Virtual reality games exercise

Other

Virtual reality games exercises 5 times per week for 12 weeks. Each participating child started the session with 5 minutes warming up exercises then followed by the main part which was consisted of 30 min of exercise where the child played the game using virtual reality X-Box and did different physical activities that included both the upper and lower extremities according to the game's requirements, and after that a 5 min cool-down part that involved some static flexibility exercises to allow the heart rate to lower, the total session that would be applied about 40 min (including 30 mins of Virtual reality exercises)

Primary outcomes

  1. Body mass index

    Time frame: From enrollment to the end of treatment at 12 weeks

    It is the weight (in kilograms) divided by the height (in meter squares)

  2. Serum triglycerides

    Time frame: From enrollment to the end of treatment at 12 weeks

    Level of triglycerides fats in blood in measured in laboratory using venous blood sample

  3. Total Cholesterol

    Time frame: From enrollment to the end of treatment at 12 weeks

    Level of total cholesterol in blood in measured in laboratory using venous blood sample

  4. High Density Lipoproteins (HDL)

    Time frame: From enrollment to the end of treatment at 12 weeks

    High Density Lipoproteins (HDL) cholesterol fats are measured in laboratory using a venous blood sample

  5. Low Density Lipoproteins (LDL)

    Time frame: From enrollment to the end of treatment at 12 weeks

    Low Density Lipoproteins (LDL) cholesterol fats are measured in laboratory using a venous blood sample

Secondary outcomes

  1. HDL ratio

    Time frame: From enrollment to the end of treatment at 12 weeks

    The number of total cholesterol divided by high-density lipoprotein (HDL)

Sponsors and collaborators

Lead sponsor

Badr University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 18, 2025
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.